Monteiro, Lis Marie 
; Löbenberg, Raimar ; Fotaki, Nikoletta; Araujo, Gabriel Lima Barros de ; Cotrim, Paulo César ; Bou-Chacra, Nadia Araci
Source: Journal of Global Antimicrobial Resistance. Unidades: FCF, FM
Subjects: QUITOSANA, LEISHMANIA, NANOTECNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, v. 18, p. 279-283, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jgar.2019.06.006. Acesso em: 30 jun. 2024.APA
Monteiro, L. M., Löbenberg, R., Fotaki, N., Araujo, G. L. B. de, Cotrim, P. C., & Bou-Chacra, N. A. (2019). Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, 18, 279-283. doi:10.1016/j.jgar.2019.06.006NLM
Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006Vancouver
Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006
